Siemens Fonds Invest GmbH Has $1.92 Million Stake in Humana Inc. (NYSE:HUM)

Siemens Fonds Invest GmbH increased its holdings in shares of Humana Inc. (NYSE:HUM - Free Report) by 23.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 7,567 shares of the insurance provider's stock after buying an additional 1,448 shares during the quarter. Siemens Fonds Invest GmbH's holdings in Humana were worth $1,920,000 as of its most recent SEC filing.

Several other hedge funds have also added to or reduced their stakes in the business. Pinnacle Wealth Management Advisory Group LLC raised its stake in Humana by 3.6% during the 4th quarter. Pinnacle Wealth Management Advisory Group LLC now owns 1,070 shares of the insurance provider's stock worth $272,000 after buying an additional 37 shares during the period. Mather Group LLC. raised its stake in Humana by 21.0% during the 4th quarter. Mather Group LLC. now owns 236 shares of the insurance provider's stock worth $60,000 after buying an additional 41 shares during the period. Capital Advisors Ltd. LLC raised its stake in Humana by 26.1% during the 4th quarter. Capital Advisors Ltd. LLC now owns 208 shares of the insurance provider's stock worth $53,000 after buying an additional 43 shares during the period. Retirement Planning Co of New England Inc. raised its stake in Humana by 4.7% during the 4th quarter. Retirement Planning Co of New England Inc. now owns 966 shares of the insurance provider's stock worth $245,000 after buying an additional 43 shares during the period. Finally, LFA Lugano Financial Advisors SA raised its stake in Humana by 56.3% during the 4th quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider's stock worth $32,000 after buying an additional 45 shares during the period. Institutional investors and hedge funds own 92.38% of the company's stock.

Wall Street Analyst Weigh In

HUM has been the topic of several research analyst reports. Raymond James raised Humana from a "market perform" rating to an "outperform" rating and set a $315.00 price objective on the stock in a research note on Thursday, May 1st. Wall Street Zen upgraded Humana from a "hold" rating to a "buy" rating in a report on Friday, May 9th. Oppenheimer increased their target price on Humana from $300.00 to $310.00 and gave the stock an "outperform" rating in a report on Thursday, May 1st. Morgan Stanley lowered their target price on Humana from $301.00 to $285.00 and set an "equal weight" rating for the company in a report on Wednesday, February 12th. Finally, Guggenheim started coverage on Humana in a report on Wednesday, April 9th. They set a "buy" rating and a $326.00 target price for the company. Sixteen analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to MarketBeat.com, the company has an average rating of "Hold" and a consensus price target of $286.81.

Humana Stock Up 1.2%

Shares of NYSE HUM traded up $2.83 during mid-day trading on Friday, hitting $232.91. The company had a trading volume of 2,524,287 shares, compared to its average volume of 1,780,835. The company has a market capitalization of $28.11 billion, a PE ratio of 23.41, a price-to-earnings-growth ratio of 2.05 and a beta of 0.49. The firm has a 50-day simple moving average of $257.11 and a two-hundred day simple moving average of $266.80. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. Humana Inc. has a one year low of $212.45 and a one year high of $406.46.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings results on Wednesday, April 30th. The insurance provider reported $11.58 EPS for the quarter, topping analysts' consensus estimates of $10.07 by $1.51. The business had revenue of $32.11 billion during the quarter, compared to analysts' expectations of $32 billion. Humana had a return on equity of 11.70% and a net margin of 1.02%. Humana's quarterly revenue was up 8.4% on a year-over-year basis. During the same quarter last year, the company posted $7.23 earnings per share. On average, equities analysts expect that Humana Inc. will post 16.47 EPS for the current year.

Humana Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be given a $0.885 dividend. The ex-dividend date is Friday, June 27th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.52%. Humana's payout ratio is 25.04%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.